Alma UK Partners With Prollenium

Alma UK, a leading provider of advanced medical aesthetics solutions, has announced a new strategic partnership with Prollenium Medical Technologies, a Canadian company renowned for its Revanesse dermal fillers. Beginning on 1st September 2024, Alma UK will become the exclusive distributor of Revanesse and SoftFil products across the United Kingdom.

This new partnership represents a key milestone for both companies, integrating Alma’s award-winning expertise in energy-based devices with Prollenium’s innovative injectable treatments. As part of this collaboration, the Prollenium UK team will integrate with Alma UK to establish the new Alma Injectables Division, which will focus on providing comprehensive, high-quality solutions to clinics throughout the UK.

According to Alma, the addition of Revanesse and SoftFil products to its existing range underscores the company’s commitment to offering cutting-edge, scientifically backed technologies.

“The strategic partnership with Prollenium and the introduction of Revanesse will allow us to bring a new era of innovation to the medical aesthetics industry,” said Lior Dayan, CEO of Alma and Sisram. “Together, we are empowered to pioneer cutting-edge solutions by delivering high-end injectable products and proprietary technologies. The UK is a strategic territory for Alma, and we are excited to bring to the kingdom a high-end injectables collection that will increase patient lifetime value and completely redefine the experience of beauty-seekers in the territory.”

Alma UK is committed to ensuring that clinics are fully equipped to utilise Prollenium’s products effectively. To this end, Alma will offer state-of-the-art training and ongoing support through Harley Academy, as well as their renowned training facilities in London, which offer stunning views of St Paul’s Cathedral. Additionally, Alma’s Global Academies and the innovative UK Clinic Marketing Accelerator Programme will further support clinics in achieving exceptional patient outcomes and business growth. This approach aims to help clinics maximise the benefits of these advanced products, ultimately enhancing both patient care and clinic performance.

For over 20 years, Alma has been a world-leading provider of energy-based solutions for the surgical, medical aesthetics, and beauty markets in more than 90 countries. The company has built a reputation for delivering high-quality, reliable technologies that meet the evolving needs of the industry.

Founded in 2002 by Ario Khoshbin, Prollenium Medical Technologies is a leading Canadian aesthetic medicine company. Known for its Revanesse hyaluronic acid dermal fillers, Prollenium expanded its offerings in 2023 by acquiring SoftFil, adding micro-cannulas and post-procedure skincare to its portfolio.

“By partnering with Alma UK, we’re combining our strengths to offer clinics a powerful synergy of advanced injectables and cutting-edge energy-based technologies, ultimately enhancing patient outcomes and clinic success.” said Ario Khoshbin, CEO of Prollenium.